Stay updated on Pembrolizumab for Metastatic Anal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now includes posted results for NCT02919969, including primary and secondary outcomes, and updated study record dates.
    Difference
    0.5%
    Check dated 2025-11-03T14:25:06.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    - Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus a version bump to v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T04:28:44.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T01:11:09.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2, replacing v3.0.1. A minor UI element 'Back to Top' was removed.
    Difference
    0.2%
    Check dated 2025-09-14T18:47:43.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T13:13:40.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while key content related to pembrolizumab and various pharmacological terms has been removed.
    Difference
    2%
    Check dated 2025-08-31T09:58:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Metastatic Anal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page.